Dr David Andrew Good - Nat Sch Physiotherapy (Faculty of Health Sciences)

Fully accredited supervisor - Can supervise as principal supervisor


I have worked in the field of biomedical research since commencing post-graduate studies in 1997. Since then I have been involved in a number of different internationally recognised research projects ranging from obesity to cancer. In 2008 helped I established the Division of Molecular and Gene Therapies within the Griffith Institute for Health and Medical Research. I was subsequently appointed the Head of the Clinical Research Unit. Some of the projects I am currently involved in include, genetics of type 2 diabetes, research into solid tumours (lung cancer, prostate, breast and colorectal cancer) and Chinese traditional medicines. In early 2009, I help establish a collaborative link with the Guangdong Pharmaceutical University in Guangdong Province China and more recently I have been responsible for establishing links with an industry partners.

Over the course of my career I have had the opportunity to teach medical students at the University of Queensland. Since 2008 I was the course convenor (lecturer-in-charge) for anatomy and physiology at Griffith University. In this role I received many student nominations for Teaching Excellence Awards. In 2010, I also received a Commendation for outstanding performance in enhancing the quality of student learning.


Phone :7657 (Brisbane)
Email :David.Good@acu.edu.au
URIs : Staff Directory Profile

Research Interests

Cancer ; Therapeutics ; Traditional medicine ; Pain ; Pain management ; Type 2 diabetes ; Obesity ;

Methods Expertise

Molecular techniques ; Microbiology ; Cell biology ; Proteomics ; Protein Assays, Tissue culture, Animal Models, ; Pain studies ;

Research Projects

Seeking Applications

  • A novel approach to manage and control Cane toads by turning the invasive pest into a valuable medicinal resource (PhD) (Co-Supervisor)
  • Liquefaction of solid tumour structure followed by an immune targeted therapy for a sequential treatment of non-small cell lung cancer (NSCLC) (PhD) (Co-Supervisor)

Current Projects

  • Quantitative sensory testing and the pain processes in osteoarthritis (PhD) (Principal Supervisor)

Selected Publications


Cancer Gene Therapy, progress and prospetives, in Gene Therapy - developments and future perspectives

MicroRNA-21 regulates TGF-beta-induced myofibroblast differentiation by targeting PDCD4 in tumour-stroma interaction., in Int J Cancer

Sequential Release of BMP-7 and VEGF from the PLGA/AK-Gelatin Composite Saffords., in Journal of Biomimetics, Biomaterials, and Tissue Engineering


New approaches in developing gene transfer vectors for the therapy of solid tumours, in Journal of Gene Medicine

Blockage of transdifferentiation from fibroblast to myofibroblast in experimental ovarian cancer models, in Molecular Cancer


Bacterial targeted tumour therapy: dawn of a new era, in Cancer Letters

"Trojan horse" vectors based on anaerobic bacteria for cancer gene therapy, in Gene Vaccine & Therapy

Clostridial spores as live "Trojan horse" vectors for cancer gene therapy: comparison with viral delivery systems, in Genetic Vaccines and Therapy

Susceptibility to insulin resistance in indigenous Australians may be down stream of resistin, in International Journal of Diabetes and Metabolism


Identification of SQSTM1/p62 mutations in familial Paget's disease in Australian pedigrees, in Bone


A genomewide search for type 2 diabetes-susceptibility genes in indigenous Australians. American Journal of Human Genetics, in American Journal of Human Genetics

Linkage of Paget's disease of bone to a novel region on human chromosome 18q23, in American Journal of Human Genetics